Immatics NV (IMTX)
9.84
+0.54
(+5.81%)
USD |
NASDAQ |
Mar 31, 16:00
9.83
-0.01
(-0.10%)
Pre-Market: 20:00
Immatics Shareholders Equity (Quarterly) : 568.55M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bayer AG | 30.47B |
| MediGene AG | -- |
| InflaRx NV | 53.31M |
| BioNTech SE | 22.58B |
| CureVac NV | 1.024B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 660.44M |
| Total Liabilities (Quarterly) | 91.89M |
| Debt to Equity Ratio | 0.0323 |
| Current Ratio | 11.72 |
| Net Debt Paydown Yield | 0.23% |